Dermatology Times, December 2021 (Vol. 42. No. 12)

A recent study investigates the probability of BDD in cosmetic dermatology with the help of a new screening tool.

The recent approval of a topical androgen receptor inhibitor fills a longtime need in acne treatment.

The past year gave dermatologists ample cause for both celebration and frustration as they looked forward to new drugs, devices, and technology to optimize patient care. Here, Dermatology Times® editorial advisory board members weigh in on the good, bad, and still-TBD changes that shaped the specialty during 2021.

Hilary Baldwin, MD, used examples of challenging cases to show how to develop successful combination regimens.

Toning and strength technologies work, according to investigators, but many in cosmetic medicine question the procedures' efficacy in their field.

A patients’ race and cultural background may be a factor in how the hair ages, according to a study in the Journal of Clinical and Aesthetic Dermatology.

Factors ranging from demographics to the COVID-19 pandemic are shifting the landscape of occupational dermatoses.

Experts detail 5 tips to ask a financial advisor so they can best serve your interests.

An expert details the ways to gain and retain new practice staff.

In this month's Cosmetic Conundrums column, Dermatology Times® Chief Medical Editor Zoe Diana Draelos, MD, explores scalp flaking causes and treatments.

In this month's Legal Eagle column, David J. Goldberg, MD, JD, discusses why sexual assault complaints must be made public, even if the defendant is found not guilty.

There are several fine nuances and differences in the presentation of atopic dermatitis in patients with skin of color that differ from the presentation seen in patients with lighter skin types. As such, clinicians should be aware of these differences to improve the treatment and management of AD in patients with skin of color.

Mark G. Lebwohl, MD, presents on what dermatologists need to know about the newest psoriasis studies during the Fall Clinical Dermatology Conference.

Racial disparities in antibiotic prescription also influence treatment decisions.

How can GEP be applied to melanoma diagnosis and treatment? Darrel Rigel, MD, MS, answers these questions and dives into the data at Fall Clinical Dermatology Conference 2021.